GLWLF.US Glow Lifetech Corp
- Market cap
- USD 5.50M
- P/E
- -
- P/B
- 2.54x
- ROE
- -12.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is GLWLF.US undervalued?
Graham numberThe Graham number of Glow Lifetech Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Glow Lifetech Corp fundamental analysis
No fundamental analysis for Glow Lifetech Corp yet.
Glow Lifetech Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Glow Lifetech Corp
Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based capsules, and market-ready products, as well as precision-dosed capsules. The company has exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology…
Full company profileGlow Lifetech Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Glow Lifetech Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 43.9K | 836K | 2.05M | 2.33M |
| Gross Profit | - | - | - | 0.00 | 25.7K | 591K | 1.36M | 1.48M |
| Operating Income | -183K | -153K | -5.28M | -2.30M | -1.59M | -1.53M | -728K | -448K |
| EBITDA | - | - | -11.3M | -1.68M | -1.31M | -1.24M | -471K | -192K |
| Net Income | -56.1K | -153K | -11.3M | -2.27M | -1.59M | -2.66M | -618K | -396K |
| EPS | 0.00 | 0.00 | -0.20 | -0.04 | -0.03 | -0.02 | 0.00 | 0.00 |
| Balance Sheet | ||||||||
| Total Assets | 20.6K | 2.60K | 3.76M | 2.31M | 1.35M | 3.72M | 3.92M | 4.18M |
| Total Liabilities | 180K | 316K | 328K | 1.14M | 2.38M | 1.15M | 1.21M | 1.11M |
| Shareholders' Equity | -159K | -313K | 3.44M | 1.16M | -1.03M | 2.57M | 2.71M | 3.07M |
| Cash & Short-term Investments | 20.5K | 1.80K | 746K | 24.1K | 34.00 | 1.29M | 1.37M | 1.60M |
| Cash Flow | ||||||||
| Operating Cash Flow | -879K | -1.39M | -1.30M | -1.30M | -453K | -1.35M | -15.0K | -626K |
| Capital Expenditure | 62.5K | 62.5K | 62.5K | 62.5K | 73.6K | 7.30K | 103K | 13.5K |
| Free Cash Flow | 16.6K | -18.7K | -3.62M | -1.36M | -527K | -1.36M | -118K | -640K |
| Ratios | ||||||||
| ROE | - | - | -329.3% | -195.0% | - | -103.4% | -22.8% | -12.9% |
| ROA | -273.0% | -5,905.3% | -300.6% | -98.4% | -117.6% | -71.4% | -15.8% | -9.5% |
| Net Profit Margin | - | - | - | - | -3,617.4% | -317.8% | -30.1% | -17.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Glow Lifetech Corp dividends
Glow Lifetech Corp has not paid dividends in the last 7 fiscal years.
Who owns Glow Lifetech Corp
- Insiders 23.18%
- Institutions 0.00%
- Public & others 76.83%
- Shares outstanding 192M
- Free float 138M
Glow Lifetech Corp company profile
- Company name
- Glow Lifetech Corp
- Ticker
- GLWLF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- 65 International Boulevard, Etobicoke, ON, Canada, M9W 6L9
- Phone
- 647-872-9982
- Website
- glowlifetech.com
About Glow Lifetech Corp
Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based capsules, and market-ready products, as well as precision-dosed capsules. The company has exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company provides its products under MOD and decimal brand names. Glow Lifetech Corp. was founded in 1988 and is headquartered in Etobicoke, Canada.
Glow Lifetech Corp management
3- Mr. Roberto Paolo CarducciCEO & Director
- Mr. Joshua Bald CPACFO & Corporate Secretary
- Mr. Tom Gladwell Ph.D.Chief Operations Officer